Oncotype DX recurrence score implications for disparities in chemotherapy and breast cancer mortality in Georgia

Among women diagnosed with stage I–IIIa, node-negative, hormone receptor (HR)-positive breast cancer (BC), Oncotype DX recurrence scores (ODX RS) inform chemotherapy treatment decisions. Differences in recurrence scores or testing may contribute to racial disparities in BC mortality among women with...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:NPJ Breast Cancer
Hlavní autoři: Collin, Lindsay J., Yan, Ming, Jiang, Renjian, Ward, Kevin C., Crawford, Brittany, Torres, Mylin A., Gogineni, Keerthi, Subhedar, Preeti D., Puvanesarajah, Samantha, Gaudet, Mia M., McCullough, Lauren E.
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group UK 2019
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6763428/
https://ncbi.nlm.nih.gov/pubmed/31583272
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41523-019-0129-3
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky